201 related articles for article (PubMed ID: 27513973)
1. Fhit loss-associated initiation and progression of neoplasia in vitro.
Karras JR; Schrock MS; Batar B; Zhang J; La Perle K; Druck T; Huebner K
Cancer Sci; 2016 Nov; 107(11):1590-1598. PubMed ID: 27513973
[TBL] [Abstract][Full Text] [Related]
2. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.
Miuma S; Saldivar JC; Karras JR; Waters CE; Paisie CA; Wang Y; Jin V; Sun J; Druck T; Zhang J; Huebner K
PLoS One; 2013; 8(11):e80730. PubMed ID: 24244712
[TBL] [Abstract][Full Text] [Related]
3. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
[TBL] [Abstract][Full Text] [Related]
4. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse.
Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
Saldivar JC; Park D
Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
[TBL] [Abstract][Full Text] [Related]
6. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract][Full Text] [Related]
7. Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
Ishii H; Vecchione A; Fong LY; Zanesi N; Trapasso F; Furukawa Y; Baffa R; Huebner K; Croce CM
Curr Gene Ther; 2004 Mar; 4(1):53-63. PubMed ID: 15032614
[TBL] [Abstract][Full Text] [Related]
8. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
9. Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.
Kitamura A; Yashima K; Okamoto E; Andachi H; Hosoda A; Kishimoto Y; Shiota G; Ito H; Kaibara N; Kawasaki H
Oncology; 2001; 61(3):205-11. PubMed ID: 11574776
[TBL] [Abstract][Full Text] [Related]
10. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
[TBL] [Abstract][Full Text] [Related]
11. A Fhit-ing role in the DNA damage checkpoint response.
Ishii H; Wang Y; Huebner K
Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
[TBL] [Abstract][Full Text] [Related]
12. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.
Kiss DL; Waters CE; Ouda IM; Saldivar JC; Karras JR; Amin ZA; Mahrous S; Druck T; Bundschuh RA; Schoenberg DR; Huebner K
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):374-382. PubMed ID: 28093273
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the role of Fhit in suppression of DNA damage.
Saldivar JC; Bene J; Hosseini SA; Miuma S; Horton S; Heerema NA; Huebner K
Adv Biol Regul; 2013 Jan; 53(1):77-85. PubMed ID: 23102829
[TBL] [Abstract][Full Text] [Related]
14. Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells.
Ji WD; Chen JK; Lu JC; Wu ZL; Yi F; Feng SM
Biomed Environ Sci; 2006 Aug; 19(4):277-84. PubMed ID: 17044645
[TBL] [Abstract][Full Text] [Related]
15. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
[TBL] [Abstract][Full Text] [Related]
16. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
[TBL] [Abstract][Full Text] [Related]
17. The FHIT gene product: tumor suppressor and genome "caretaker".
Waters CE; Saldivar JC; Hosseini SA; Huebner K
Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
[TBL] [Abstract][Full Text] [Related]
18. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
19. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.
Roz L; Gramegna M; Ishii H; Croce CM; Sozzi G
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3615-20. PubMed ID: 11891319
[TBL] [Abstract][Full Text] [Related]
20. Fhit tumor suppressor: guardian of the preneoplastic genome.
Pichiorri F; Palumbo T; Suh SS; Okamura H; Trapasso F; Ishii H; Huebner K; Croce CM
Future Oncol; 2008 Dec; 4(6):815-24. PubMed ID: 19086848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
